-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Text|Medical big cow cat
Recently, many domestic media have rushed to report that Israeli medical staff have obtained a new drug EXO-CD24 that has a significant effect on the new coronavirus infection
Although the number of clinical trials is limited, the efficacy results are very positive
Although the number of clinical trials is limited, the efficacy results are very positivePreviously, the results of clinical trials of the drug showed that 21 patients were tested, and 19 patients showed significant improvement within a few days and were discharged after a week
EXO-CD24 is an immune drug that specifically suppresses cytokine storm
EXO-CD24 is an immune drug that specifically suppresses cytokine stormAlthough the detailed structure of EXO-CD24 is not known, we know that CD24 is involved in the process of autoimmunity in the body's immune response
In the human body, how does the drug achieve its curative effect?
In the human body, how does the drug achieve its curative effect?This protein, called CD24, is delivered to the lungs through the exosomes in the drug, which helps to rebalance the immune system and prevent it from overreacting to the virus
If the efficacy of the drug EXO-CD24 can be determined through a large sample of clinical trials, it will bring a great chance of survival to severely ill patients with new coronary infection
EXO-CD24 was originally a targeted anti-cancer drug
EXO-CD24 was originally a targeted anti-cancer drugEXO-CD24 was originally a targeted anti-cancer drug, and it is reported to be used to treat certain types of cancer
summary
summaryIn short, although the number of patients participating in clinical trials of EXO-CD24 is relatively small, the existing results show very positive clinical effects
